Sterling Financial Planning, Inc. Edwards Lifesciences Corp Transaction History

Sterling Financial Planning, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$106.37 - $130.68 $78,181 - $96,049	-735 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$102.91 - $122.75 $5,145 - $6,137	-50 Reduced 6.37%	735 $83,000
Q1 2021 Apr 28, 2021	SELL	$78.68 - $90.67 $28,718 - $33,094	-365 Reduced 31.74%	785 $66,000
Q4 2020 Feb 10, 2021	BUY	$71.69 - $91.23 $82,443 - $104,914	1,150 New	1,150 $105,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Sterling Financial Planning, Inc., based on Form 13F filings with the SEC.

Stay updated on Sterling Financial Planning, Inc. with notifications on news.